Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
Atypical chronic myeloid leukemia is a rare disease whose pathogenesis has long been debated. It currently belongs to the group of myelodysplastic/myeloproliferative disorders. In this review, an overview on the current knowledge about diagnosis, prognosis, and genetics is presented, with a major fo...
Guardado en:
Autores principales: | Diletta Fontana, Carlo Gambacorti-Passerini, Rocco Piazza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/861bc3225c5d4c17958485b0290ca4f5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview
por: Andrea Kuendgen, et al.
Publicado: (2021) -
TRANSCRIPTOS DE FUSIÓN DEL GEN BCR/ABL EN PACIENTES CON LEUCEMIA MIELOIDE CRÓNICA
por: Artigas,Carmen Gloria, et al.
Publicado: (2003) -
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
por: Amin Huma, et al.
Publicado: (2021) -
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
por: Oksana Montecchini, et al.
Publicado: (2021) -
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
por: Haidée Aranda-Tavío, et al.
Publicado: (2021)